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TUMOUR necrosis factor (TNF) inhibits the accumulation
of acetyl CoA carboxylase (ACC) mRNA by decreasing
the rate of ACC gene transcription. The ACC mRNA
species found in 30A5 cells are generated from promoter
II and TNF inhibits the accumulation of class 2 type
mRNAs. By using 5’ deletion mutants ofpromoter II fused
to the bacterial chloramphenicol acetyltransferase (CAT)
gene, the DNA mobility shift assay and the DNase I
footprinting assay, the authors have identified the 30 bp
from --389 to --359 as the TNF responsive element in
promoter II. TNF treatment causes a decrease in the
binding activity of nuclear protein(s) specific to the TNF
responsive element. When the fragment containing the
TNF responsive element was incorporated into the
thymidine kinase promoter, the chimeric gene exhibited
TNF induced inhibition of expression.
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Introduction
The presence of a chronic infection or
malignancy induces macrophages to produce TNF
and subsequently drives bodily metabolism towards
a constitutive catabolic state, the primary character-
istic of cachexia. A hallmark of cachexia is the
depletion of lipid reserves from adipocytes and the
accumulation of serum lipids. Oliff and co-workers
have demonstrated that nude mice harbouring solid
tumours which secrete TNF display ’cancer-
associated cachexia’. These mice show a marked
loss of intrascapular fat pads, perirenal and
subcutaneous fat. Although it is difficult to directly
assess the role of TNF in altering fat depots and
inducing cachexia in this animal model,2’3 it is
apparent that TNF has a marked effect on lipid
metabolism. This is also borne out in other
systems.
4-7
TNF completely inhibits the conversion of
3T3-L1, TA1 and 30A5 preadipocytes to adipo-
cytes in in vitro culture systems.
4-7 In addition, TNF
can also induce fully differentiated adipocytes to
revert to a preadipocyte like state under certain
culture conditions.68 The aim of this work has been
to understand how TNF alters lipid metabolism by
studying the effect of the monokine on acetyl CoA
carboxylase gene expression in 30A5 preadipocytes.
Acetyl CoA carboxylase (ACC) catalyzes the
rate-limiting step in the biosynthesis of long-chain
fatty acids.
9 It has been shown that TNF completely
inhibits the conversion of 30A5 preadipocytes to
adipocytes with the concomitant inhibition of the
accumulation of ACC mRNA.5’1 TNF suppresses
ACC mRNA accumulation by decreasing the rate
of transcription of the ACC gene.
1 ACC mRNA
exists in multiple forms which are generated as a
result of differential splicing of two primary
transcripts of two distinct promoters, promoters I
and II. 11’12 Expression of these promoters is tissue
specific and dependent upon physiological condi-
tions. In the case of 30A5 cells, the primary gene
products are those mRNAs produced under the
influence of promoter II, and there is little or no
ACC mRNA from promoter 1.13 In this paper, the
promoter II region of the ACC gene which confers
TNF responsiveness to the gene has been
characterized. The authors show that a 30 bp
fragment in the 5’ flanking sequences of the ACC
gene confers TNF mediated inhibition of transcrip-
tion. In addition, evidence that specific binding of
nuclear proteins to the 30 bp fragment is decreased
upon treatment of 30A5 cells with TNF, is
presented.
Materials and Methods
Materials: The following commercial products
were used: Eagle basal medium (MA Bioproducts,
Walkersville, MD); foetal bovine serum (GIBCO
Laboratories, Grand Island, NY); dexamethasone
and insulin (Collaborative Research, Inc., Waltham,
MA); T4 DNA polynucleotide kinase, restriction
enzymes (New England Biolabs, Beverly, MA);
DNA polymerase Klenow fragment, DNase I,
exonuclease 1II, and calf intestinal alkaline phospha-
tase (Boehringer Mannheim, Indianapolis, IN);
14C-labelled chloramphenicol, [y-32p]-adenosine 5’-
triphosphate (Amersham, IL); recombinant human
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TNF-a (2.7 x 107 U/mg) was generously provided
by Dr Tatsuro Nishihara of the Suntory Institute,
Osaka, Japan.
Cell culture: The 30A5 preadipocyte cells were grown
in Eagle basal medium containing 10% foetal
bovine serum or bovine calf serum (Hyclone,
Logan, UT) as described previously.
14 TNF
included in the medium at a concentration of
200 U/ml, from day 0 (the day of confluence,
D-0) prevents differentiation under two differ-
entiation schemes. 14 These cells are called TNF
treated preadipocytes.
Plasmid constructions: Construction of the plasmids,
pUC-CAT3 and plasmid pPII-CAT0 has been
described previously.
12 The plasmid pPII-CAT0
contains the --994 to +62 (relative to the first
transcription initiation start site) region of promo-
ter II in a 5’ to 3’ orientation relative to the CAT
gene. The exonuclease Ili method and standard
recombinant DNA techniques
is were used to
generate a series of 5’ deletion mutants of ACC
promoter II. The end point and orientation of the
deletions were determined by DNA sequencing.s
Putative regulatory elements were placed into
a thymidine kinase (TK)/CAT fusion gene.
pTK-CAT
12 which contains the 109/+ 51 region
of the TK promoter distal to the CAT gene was
digested at the unique Sail site and filled in.
Various fragments ofACC promoter II, as indicated
in the text, were blunt-end ligated into this site.
The synthesized mouse TNF responsive se-
quence spanning --370 to --340 was flanked by
Sac1 restriction sites and used for cloning. These
oligonucleotides are as follows:
5’-GGTGGAGGTTGGCCGGCCCAAACCCGC-
CTAGCT-3’, and 5’-AGGCGGGTTTGGGCCG-
GCCAACCTCCACCAGCT-3’. The synthesized
complementary strands were annealed, phosphor-
ylated by T4 polynucleotide kinase and ligated into
pPlI-CAT4 plasmid vector which was digested
with SacI restriction enzyme and dephosphorylated
with calf intestinal alkaline phosphatase. All
constructed mutants were confirmed by DNA
sequencing,
is The features of all gene constructs
used are shown in Fig. 1.
Transfections and CAT assays: Cell monolayers at
80-90% confluence were transfected with 20 #g of
ACC-CAT construct DNA by coprecipitation with
calcium phosphate.
16 Cells were exposed to the
precipitate for 8 h at which time fresh medium with
or without 200 U/ml ofTNF was added. Cell lysates
were made 60 h later by sonication in 150 #1 of
0.25 M Tris-HC1, pH 8.0 followed by heating at
60C for 10min to minimize the effect of
deacylating agents in the CAT assay.
17 The CAT
assay was performed essentially as described.
16
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FIG. 1. Schematic diagram of pPII-CAT and pPII-TK constructs. (A)
Acetyl CoA carboxylase promoter II fragments were inserted upstream of
the CAT gene in pUC-CAT3. The numbers in the figures refer to the
nucleotide positions in the promoter; the value +1 was assigned
to the transcription initiation site. (B) The promoter fragment ranging
from 434 to 285 was inserted in front of pTK-CAT to create pPI I-TK2.
Protein amount was determined using the Bradford
reagent with bovine serum albumin as the
standard.
4 CAT activity was expressed as percent-
age chloramphenicol acetylated per h per mg
protein. A beta-actin-CAT construct
8 was included
in each experiment to correct for any differences in
transfection efficiency.
Preparation of nuclear extracts: Nuclear extracts were
prepared according to the method ofDignam et al.
19
30A5 cells at D + 4 which were fully differentiated
by the cAMP pretreatment differentiation scheme,
14
or the cells at D+4 which were kept in TNF
(200 U/ml) during the same differentiation scheme,
were used for preparations. Nuclear extracts were
divided into small aliquots, quickly frozen in liquid
nitrogen and stored at -80C.
DNA mobility shift assays: For oligonucleotides, both
complementary single-stranded 30-reefs (-389 to
-359) were end-labelled separately. The labelled
30-mers were annealed in 140 mM KC1 and purified
by gel electrophoresis in a 20% polyacrylamide gel
or by using a Chroma Spin + TE-10 column. The
labelled DNA fragments were incubated with 10 pg
of nuclear proteins on ice for 30 min, in 20 #1 of
binding buffer (5 mM MgCI2, 5 mM DTT, 1 mM
EDTA, 50 mM KC1, 10 mM HEPES, pH 7.9, 10%
glycerol, and 1 #g poly (dI.dC). For competition
experiments, different molar concentrations of
non-labelled specific competitors or nonspecific
competitors were added to the reactions. DNA
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mobility retardation was analyzed by a 4%
polyacrylamide gel electrophoresis, and autoradio-
graphy.
DNase I footprinting: The labelled probe for the
DNase I footprinting analysis was pPII-TK2 which
contains the ACC promoter II fragment from -434
to -285 in pTK-CAT vector using blunt-ended
Sal I site. pPII-TK2 was digested with HindIII
restriction enzyme, dephosphorylated with calf
intestinal alkaline phosphatase, and radiolabelled by
using [y-32p]ATP and T4 polynucleotide kinase.
The labelling was followed by EcoRI digestion.
The 224 bp labelled fragment containing the ACC
promoter fragment (--434 to --285) and 34 bp of
TK promoter sequences was isolated through
electrophoresis from the gel following its separa-
tion. Five nanograms (20 000 cpm) of the labelled
DNA fragment was incubated with 40g of nuclear
extracts in a binding reaction (50/,1) at 0 C for
30 min. The binding mixture was then subjected to
DNase I (2/,1 of DNase I solution containing
different units of the enzyme as specified) treatment
at room temperature for 2 min. The reaction was
terminated by addition of 120 #1 stop buffer (30 mM
EDTA, 1% SDS, 300 mM NaC1 and 250#g of
tRNA per ml). Samples were deproteinized by
extraction with phenol-chloroform-isoamyl alco-
hol 25:24:1), precipitated with ethanol, and loaded
onto an 8% denaturing polyacrylamide gel.
Results
Identification of cis-acting DNA elements mediating TNF
responsiveness: In 30A5 cells, ACC mRNA species are
synthesized under the influence of promoter II
(PII), one of the two promoters in the ACC gene,
and no detectable ACC mRNA species are
synthesized from promoter I.
13 TNF inhibits the
rate of transcription of the ACC gene during the
transformation of 30A5 preadipocyte to adipo-
10 cytes.
A series of 5’ deletion mutants in which deleted
fragments ofACC promoter I1 were fused upstream
of the CAT gene
12 was prepared as shown in Fig.
1A, and the effect of the promoter I1 fragment on
CAT gene expression was assessed in a transient
expression system (Fig. 2). The data indicate that
there are several regions within the --674 to + 62
sequences important in the expression of the ACC
gene (Fig. 2). The --674 to --434 region appeared
to contain a negative control element as CAT
activity increased about three-fold when this
sequence was deleted. However, the --434 to --135
region contained positive elements as evidenced by
the decrease in CAT activity when these sequences
were deleted. The most important positive element
appeared to lie between -285 and -135, as a
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FIG. 2. Relative transcription rates of 5’ deletion mutants of acetyl CoA
carboxylase promoter II. Various carboxylase promoter I/CAT constructs
as shown in Fig. 1A were transfected into subconfluent 30A5 cells
followed by a 60 h incubation in the absence or presence of TNF. The
CAT activity obtained from pPII-CAT1 which was included in each
experiment was set as 100%. The number of plates used to obtain data
for each bar is indicated. Error bars indicate the range of three
determinations. The size of PII in each construct is: pPII-CAT1,
-674/+62; pPII-CAT2, -434/+62; pPII-CAT3, -340/+62; pPII-
CAT4, -285/+62; pPII-CAT5, -135/+62; pPII-CAT6, -35/+62. I--I,
Control; I TNF.
greater than ten-fold decrease in CAT activity
resulted when pP11-CAT4 and pPII-CAT5 were
used. Recently, the authors reported the presence
of a strong enhancer sequence in this region which
is neither promoter specific nor orientation
specific.
12
To determine if TNF could suppress the
expression of the CAT gene in these chimeric gene
constructs, TNF was added to 30A5 preadipocytes
after transfection with the various constructs.
Figure 2 shows that the sequences responsible for
TNF mediated inhibition of ACC gene transcrip-
tion do indeed lie within the -674 to + 62 region.
Plasmids pPII-CAT1 and pPII-CAT2 showed
about 70% suppression of CAT activity upon TNF
treatment in comparison to untreated controls.
However, pPII-CAT4, pPII-CAT5, and pPII-
CAT6 did not show suppression by TNF, suggest-
ing that the elements responsible for mediating the
TNF effect may lie between -434 and -285. To
further define the role of these sequences in
mediating the TNF response, we inserted a
fragment spanning the --434/--285 region up-
stream to the thymidine kinase promoter which was
linked to the CAT gene (Fig. 1B). When placed
distal to the thymidine kinase promoter in
pTK-CAT, the 150 bp fragment conferred TNF
responsiveness to the TK promoter (Fig. 3). TNF
caused about a 65% suppression of CAT activity in
pPII-TK2. Previously, the authors reported that
TNF treatment of 30A5 cells decreased the rate of
transcription of the ACC gene by 60 to 70%.l Thus,
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FIG. 3. Effect of acetyl CoA carboxylase promoter II sequences in a
TK/CAT construct. The sequence spanning -434 to -285 was placed
distal to the TK promoter in pTK-CAT to form pPII-TK2. The effect of
TN F on CAT activity was assayed as described in Materials and Methods.
The CAT activity obtained from pTK-CAT was set as 100%. The number
of plates used to obtain data for each bar is indicated. Error bars indicate
the range of three determinations. Key as Fig. 2.
these experiments show that the effect of TNF is
mediated by a ch element in the --434/--285
region.
Nuclearproteins binding to the TNF responsive element: The
--434 to --285 region and its relationship to TNF
action on ACC promoter II was further char-
acterized by determining whether specific nuclear
proteins interacted with these sequences. To do
this, DNase I footprinting analysis was performed
using DNA fragment--434 to --285 of promoter
II which was labelled at the 5’ end of the non-sense
strand, and nuclear extracts prepared from cells
with or without TNF treatment (Fig. 4). This
analysis reveals that a 30 base pair from -389 to
--359 of the non-sense strand was protected in the
presence of the nuclear extracts from the
differentiated cells (Fig. 4, lane 3) whereas the
nuclear extracts from the TNF treated cells did not
protect the same region (Fig. 4, lane 4). Nuclear
extracts from the pre-adipocytes also did not protect
the region, as shown in Fig. 4, lane 2. In order to
further characterize the nuclear proteins bound to
the TNF responsive region spanning --389 to
--359, the 30 base pair sequence from -389 to
-359 was synthesized and the DNA mobility shift
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FIG. 4. DNase footprinting analysis of DNA-protein interactions at ACC
promoter I1. Footprinting analysis was performed with the -434 to -285
fragment of pPII-TK2 construct labelled in the non-sense strand (lanes
to 4). The probes were incubated with nuclear extracts (40 #g) from
30A5 preadipocytes at confluency (lane 2) or the fully differentiated
adipocytes at day +4 (lane 3) or TNF treated cells at day +4 (lane 4).
These binding mixtures were then subjected to DNase (0.5 U/2 #1 for
lane 1, 5U/2#1 for lanes 2 through 4) treatment for 2 min at room
temperature as described in Materials and Methods. Lane indicates the
free probe DNA. Lane m represents the molecular weight markers r,-32p]
end labelled Hpall fragments of pUC 19) whose lengths in nucleotides
are indicated to the right. The protected regions are indicated by arrows
and the numbers correspond to the position of the nucleotides relative
to the transcription initiation site. The protected sequences of the ACC PII
promoter are shown in the figure.
analyses were performed (Figs 5 and 6). Four DNA
bands were shifted ina sequence specific manner in
the competition experiment (Fig. 5) and the
formation of one of the four bands decreased when
the cells were treated with TNF, as shown in Fig.
6, lane 2. In a separate experiment, it was
determined that bands 1 and 2 are due to the
binding of Sp1 to the 30-met probe (data not
shown).TNF regulation of acetyl CoA carboxylase transcription
DIFF. TNF
D+4
free-
FIG. 5. DNA mobility shift binding profile. The ACC promoter II fragment
spanning from -389 to -359 was end labelled and used for the binding
assays as described in Materials and Methods. The nuclear extracts from
differentiated 30A5 cells (D+4) were added to the binding reactions.
The molar excess of unlabelled competitor DNA in the binding mixtures
is indicated above each lane. Lane 1, the 32p labelled DNA probe; lanes
2 to 5, the labelled 30-mer probe DNA in the presence of 30A5 nuclear
extracts; lanes 3 and 4, in the presence of different amounts of the same
unlabelled 30-mer; lane 5, in the presence of a nonspecific sequence
(30-mer) of the ACC promoter fragment spanning from 291 to 207.
1 2
FIG. 6. DNA mobility retardation profile by nuclear proteins. End labelled
30-mer probe (-389 to -359), (0.2 ng), was incubated in the presence
of nuclear proteins (10 #g) on ice for 30 min. The mobility of the retarded
probe DNA was analysed through a 4% polyacrylamide gel as described
in Materials and Methods. Lanes and 2, labelled DNA (-389/-359)
in the presence of the nuclear proteins from differentiated 30A5 cells
(D+4) and 30A5 cells treated with TNF for the same period of time
(D+4).
Eect of 389/-- 359 on TNF responsiveness: To further
establish that the sequences in the -389/-359
region are responsible for binding the nuclear
proteins whose binding activities were diminished
by the treatment of cells with TNF, the effect of
the addition of the --389/-359 fragment to
pPII-CAT4 on the expression of CAT activity was
examined (Fig. 7). The plasmid containing the 30
base pairs was prepared as follows. Plasmid
pPII-CAT4 was linearized with SacI, blunt-ended
by T4 DNA polymerase, and then the -389/-359
fragment was inserted in the site to create
pPII-CAT8 (Fig. 1A). TNF inhibited the expres-
sion of the CAT gene in plasmid pPII-CAT2 by
about 70%. However, CAT activity in plasmid
pPII-CAT4 which does not contain the -434/
-285 region was not inhibited by TNF. However,
when the 30 bp fragment was placed in the
pPII-CAT4 (pPII-CAT8), TNF responsiveness
was reversed to an inhibition level of about 70%.
These data suggest that the sequences within
-389/-359 are responsible for conferring TNF
responsiveness on the ACC gene. The sequence of
this 30 bp region is GGTGAGCCGTTGGGCTG-
CCCaCCCCC (g. 8).
Effect of the mouse TNF responsive region on TNF mediated
transcription suppression: In a separate experiment, we
identified a TNF responsive sequence in the mouse
gene that is homologous to the rat gene. The mouse
ACC promoter sequence spanning the -370 to
--340 region is highly homologous to the 30-mer
sequence of the rat gene (Fig. 8). To examine
whether or not the mouse sequence (--370 to
-340) also shows TNF mediated transcription
suppression, the synthesized mouse 30-mer was
inserted in pPII-CAT4 vector which was linearized
with SacI and blunt-ended to construct pPII-CAT4
mTNF No. 3 (right orientation) and No. 22
(opposite orientation). We examined the effects of
TNF on two constructs with the 30-met in either
direction as shown in Fig. 9. In comparison to
pPII-CAT4 as a negative control and pPI1-CAT 2
as a positive control, TNF inhibited the expression
of the CAT gene by about 60% with both the mouse
constructs. These results show that the mouse
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FIG. 7. Effect of the 30-mer cis element (-389/-359) on TNF action.
The constructed plasmid (pPII-CAT8, Fig. 1A) containing the fragment
(-389/-359) at the position -285 (pPII-CAT4) was transfected into
80-90% confluent 30A5 cells. The cells were harvested for CAT assay
after 60 h of incubation in the presence or absence of TNF. The CAT
activity obtained from pPII-CAT1 which was included in each experiment
was set as 100%. The number of plates used to obtain data for each bar
is indicated. Error bars indicate the range of three determinations. Key as
Fig. 2.
Rag’ (-389) GGTGAGCCGTTGGGCTGGCCCAAACCGCCC (-359)
Mouse’ (-370) fiGTGGAGGTTGfiCCGGCCCAAACCCGCCTA (-340)
FIG. 8. TNF responsive sequences rat and mouse.
sequence also effectively mediates TNF effect on the
gene expression in spite of minor differences in
sequence from that of rat.
Discussion
The effect of TNF on 30A5 preadipocytes has
proved extremely useful for detailed study of ACC
gene expression and thus, for elucidating the
underlying molecular mechanisms for TNF action.
Several investigators have studied the effect ofTNF
on lipogenic genes in various preadipocyte cell lines
and in all cases TNF has been shown to inhibit the
expression of this class of genes as determined by
measuring their respective mRNA amourits.4’2’21 In
some cases, direct measurement of transcription
rates by either labelling cellular RNA or nuclear
run-off transcription assays reveals that the decrease
in the amount of mRNA for the lipogenic gene
under study is due to inhibition of gene
transcription.1’2 Such studies suggest that TNF
response elements exist at the 5’ end of these
lipogenic genes to confer TNF mediated inhibition
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FIG. 9. Effect of the mouse TNF responsive region on expression of
ACC-CAT construct. Two mouse constructs, pPI I-CAT4 mTN F No. 3 and
No. 22, were transfected into 80% confluent 30A5 preadipocytes together
with pPII-CAT2 and pPII-CAT4. Sixty hours later, CAT activities in cell
lysates were assayed. The CAT activity of pPII-CAT1 included in this
experiment was taken as 100%. Error bars indicate the range of three
determinations. Key as Fig. 2.
of transcription. The authors provide evidence that
such elements do exist in at least one lipogenic gene,
i.e. the ACC gene, and these elements can confer
TNF responsiveness to a non-lipogenic promoter.
Construction of 5’ deletion mutants of ACC
promoter II placed upstream of the CAT gene
revealed that the -434 to +62 region inhibited
CAT activity approximately 70% upon TNF
treatment in comparison to controls. Further
deletions appeared to limit the TNF response as the
--340 to -t-62 construct only suppressed CAT
activity by about 30%. In many different experi-
ments, we have observed that TNF can suppress
about 30% of any gene construct irrespective of the
nature of the promoters. These observations
suggest that TNF action independent of the cis
acting sequences in the promoters may still exist.
These observations together with the results
reported in this paper, suggest that the effect of
TNF is mediated through multifaceted events. One
of these is mediated through the cis acting elements
in the promoter, in this case, ACC promoter II in
combination with nuclear trans acting factors.
TNF treatment of 30A5 ceils reduces the specific
binding of nuclear proteins to the --389/--359
region of ACC promoter II. Whether the reduced
binding is the result of a decrease in the amount of
these factors, or some post-translational modifica-
tion, is currently under study. The nature of theseTNF regulation of acetyl CoA carboxylase transcription
trans acting factors is unknown; a careful search for
consensus sequences of known transcription
factors22-24 does not reveal strong homologies. In
addition, a homology search for the 5’ ends of other
lipogenic genes also yields minimal homology.
Thus, the transcription factors responsible for
mediating the TNF responsiveness of ACC
promoter II may be novel in both sequence
specificity and/or regulatory properties.
Repression of a eukaryotic gene can occur
through induction of repressor, or conformational
changes in activator molecules, i.e. glucocorticoid
receptor molecules bound to the glucocorticoid
responsive element in the promoter region. During
the action of TNF, it is found that the nuclear
binding proteins on the 30-mer region diminished
either through modification or a decrease in their
amount. A simply hypothesis is that the binding of
the nuclear protein is essential for activation of the
ACC gene, the promoter, and that a decrease in
binding activity results in repression. However,
such regulatory mechanisms are rare. Recently,
Brennan et al. 25 reported that serum, which inhibits
myoblast differentiation, and thus various asso-
ciated aspects of phenotypic gene expression,
diminished the in vitro DNA binding activity of
myogenin, suggesting that serum inhibition of
myogenesis is due to the attenuation of the DNA
binding activity of myogenin.
The underlying mechanism(s) for the decrease in
the binding activities in the present case, or the
effect of serum on myogenesis,
25 is not known,
although a mechanism such as covalent phosphoryl-
ation can easily be envisaged.
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